• 1
    Ribatti D., Vacca A., Roncali L., Dammacco F., Hematopoiesis and angiogenesis: a link between two apparently independent processes. J. Hematother. Stem Cell Res., 9: 1319, 2000.
  • 2
    Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C., Failure of blood-island formation and vasculogenesis in FLK-1 deficient mice. Nature, 376: 6266, 1995.
  • 3
    Shalaby F., Ho J., Stanford W.L., Fisher K.D., Schuh A.C., Schwartz L., Bernstein N.A., Rossant J., A requirement for flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell, 89: 981990, 1997.
  • 4
    Eichmann A., Corbel C., Nataf V., Vaigot P., Breant C., Le Douarin N.M., Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor-2. Proc. Natl. Acad. Sci. USA, 94: 51415146, 1997.
  • 5
    Nishikawa S.I., Nishikawa S., Hirashima M., Matsuyoshi N., Kodama H., Progressive lineage analysis by cell sorting and culture identifies FLK+ VE-cadherin+ cells at a diverging point of endothelial and hematopoietic lineages. Development, 125: 17471757, 1998.
  • 6
    Ribatti D., Vacca A., Nico B., Ria R., Dammacco F., Cross-talk between hematopoiesis and angiogenesis signaling pathways. Curr. Mol. Med., 2: 537547, 2002.
  • 7
    Asahara T., Murohara T., Sullivan A., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M., Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275: 964967, 1997.
  • 8
    Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res., 85: 221228, 1999.
  • 9
    Peschle C., Botta R., Muller R., Valtieri M., Ziegler B.L., Purification and functional assay of pluripotent hematopietic stem cells. Rev. Clin. Exp. Hematol., 5: 314, 2001.
  • 10
    Kennedy L.J., Weissmann I.L., Dual origin of intimal cells in cardiac-allograft arteriosclerosis. N. Engl. J. Med., 285: 884887, 1971.
  • 11
    Frazier O.H., Baldwin R.T., Eskin S.G., Duncan J.M., Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex Heart. Inst. J., 20: 7882, 1993.
  • 12
    Grefte A., Blom N., van der Giessen M., van Son W., The T.H., Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. J. Infect. Dis., 168: 11101108, 1993.
  • 13
    Hladovec J., Prerovsky I., Stanek V., Fabian J., Circulating endothelial cells in acute myocardial infarction and angina pectoris. Klin. Wochenschr., 56: 10331036, 1978.
  • 14
    Lefevre P., George F., Durand J.M., Sampol J., Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura. Thromb. Haemost., 69: 522, 1993.
  • 15
    Solovey A., Lin Y., Browne P., Choong S., Wayner E., Hebbel R.P., Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med., 337: 15841590, 1997.
  • 16
    Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P., Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest., 105: 7177, 2000.
  • 17
    Rafii S., Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest., 105: 7177, 2000.
  • 18
    Poole T.J., Finkelstein E.B., Cox C.M., The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev. Dyn., 220: 117, 2001.
  • 19
    Peichev M., Naiyer A.J., Bereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Rafii S., Expression of VEGFR-2 and AC 133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood, 95: 952958, 2000.
  • 20
    Gehling U.M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., Schuch G., Schafhausen P., Mende T., Kilic N., Kluge K., Schafer B., Hossfeld D.K., Fiedler W., In vitro differentiation of endothelial cells from AC 133-positive progenitor cells. Blood, 95: 31063112, 2000.
  • 21
    Quirici N., Soligo D., Caneva L., Servida F., Bossolasco P., Deliliers G.L., Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br. J. Haematol., 115: 186194, 2001.
  • 22
    Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Suavage L.R., Moore M.A., Storb R.F., Hammond W.P., Evidence for circulating bone marrow-derived endothelial cells. Blood, 92: 362367, 1998.
  • 23
    Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J.M., VEGF contributes to postnatal neovascularization by mobilizing bone-marrow derived endothelial progenitor cells. EMBO J, 18: 39643972, 1999.
  • 24
    Gill M., Dias K., Hattori M.L., Rivera D., Hicklin L., Witte L., Girardi L., Yurt R., Himel H., Rafii S, Vascular trauma induces rapid but transient mobilization of VEGFR2(+) AC133(+) endothelial precursor cells. Circ. Res., 88: 167174, 2001.
  • 25
    Ikpeazu C., Davidson M.K., Halterman D., Browning P.J., Brandt S.J., Donor origin of circulating endothelial progenitors after allogenic bone marrow transplantation. Biol. Blood Marrow Transplant., 6: 301308, 2000.
  • 26
    Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T., Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA, 938: 34223427, 2000.
  • 27
    Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Graveraux E., Pieczek A., Iwaguro H., Hayashi S.I., Isner J.M., Asahara T., Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res., 86: 11981202, 2000.
  • 28
    Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med., 7: 430436, 2001.
  • 29
    Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Witte L., Girardi L., Yurt R., Himel H., Rafii S., Impaired recruitment of bone marrow derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med., 7: 11941201, 2001.
  • 30
    Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., Verfallie C.M., Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest., 109: 337346, 2002.
  • 31
    Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T., Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cell for neovascularization. Nature Med., 5: 434438, 1999.
  • 32
    de Palma M., Venneri M.A., Roca C., Naldini L., Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopietic stem cells. Nature Med., 9: 789795, 2003.
  • 33
    Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal Ginard, B., Bodine D.M., Leri A., Anversa P., Bone marrow cells regenerate infarcted myocardium. Nature, 410: 701705, 2001.
  • 34
    Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., Hicklin D.J., Zhu Z., Witte L., Crystal R.G., Moore M.A., Rafii S., Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med., 193: 10051014, 2001.
  • 35
    Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., Silver M., Li T., Isner J.M., Asahara T., Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation, 105: 732738, 2002.
  • 36
    Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner .JM., Asahara T., Stromal cell derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation, 107: 13161322, 2003.
  • 37
    Mohle R., Bautz F., Rafii S., Moore M.A., Brugger W., Kanz L., The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood, 91: 45234530, 1998.
  • 38
    Rehman J., Li J., Orschell C.M., March K.L., Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107: 11641169, 2003.
  • 39
    Vu T.H., Werb Z., Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev., 14: 21232133, 2000.
  • 40
    Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., Henriksen K., Lenhard T., Foged N.T., Werb Z., Delaisse J.M., Matrix metalloproteinase-9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol., 151: 879890, 2000.
  • 41
    Ribatti D., Vacca A., Dammacco F., The role of vascular phase in solid tumor growth: a historical review. Neoplasia, 1: 293302, 1999.
  • 42
    Ribatti D., Vacca A., Dammacco F., New non-angiogenesis dependent pathways for tumor growth. Eur. J. Cancer, 39: 18351841, 2003.
  • 43
    Mancuso P., Burlini A., Pruneri G., Goldhirsch A., Martinelli G., Bertolini F., Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood, 97: 36583661, 2001.
  • 44
    Monestiroli S., Mancuso P., Burlini A., Pruneri G., Dell'Agnola C., Gobbi A., Martinelli G., Bertolini F., Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res., 61: 43414344, 2001.
  • 45
    Vajkoczy P., Blum S., Lamparter M., Mailhammer R., Erber R., Engelhardt B., Vestweber D., Hatzopoulos A.K., Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J. Exp. Med., 197: 17551765, 2003.
  • 46
    Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., Di Palma, T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D., Persico M.G., Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Med, 7: 575583, 2001.